Today: 7 February 2026
Subscribe
Browse Category

Medical Technology News 23 January 2026 - 6 February 2026

Haemonetics stock slides 7% as revenue dip and hospital softness blunt raised outlook

Haemonetics stock slides 7% as revenue dip and hospital softness blunt raised outlook

Haemonetics shares dropped 7% Friday to $60.46 despite the company raising its full-year profit and cash flow outlook. Third-quarter revenue fell 2.7% to $339 million, while adjusted EPS rose to $1.31. Interventional technology revenue declined 12%, offsetting a 3% gain in plasma. Citigroup cut its price target to $75.
6 February 2026
·····
Boston Scientific stock price steadies after historic plunge as investors zero in on heart-rhythm outlook

Boston Scientific stock price steadies after historic plunge as investors zero in on heart-rhythm outlook

Boston Scientific shares slipped 0.2% to $77.49 in late-morning trading Friday, lagging a broader market rally. The stock remains under pressure after its electrophysiology segment missed sales estimates in the fourth quarter, triggering its steepest drop in over 25 years. Investors are watching for signs management can meet first-quarter growth targets. Trading volume stayed elevated as analysts revised forecasts.
6 February 2026
····
Boston Scientific stock rebounds after earnings shock as analysts cut targets on EP worries

Boston Scientific stock rebounds after earnings shock as analysts cut targets on EP worries

Boston Scientific shares rose 2.8% to $77.64 in Thursday’s after-hours trading, rebounding after a record 17% plunge Wednesday on weak Q4 electrophysiology and Watchman sales. Citi and Wells Fargo lowered price targets but kept positive ratings. Fourth-quarter net sales reached $5.29 billion, with adjusted EPS of $0.80. The company expects 2026 adjusted EPS of $3.43–$3.49.
6 February 2026
·····
Why Johnson & Johnson stock is up today: new Varipulse Plus update puts AFib data back in play

Why Johnson & Johnson stock is up today: new Varipulse Plus update puts AFib data back in play

Johnson & Johnson shares rose about 1.4% to $233.87 Tuesday after unveiling new pulsed-field ablation and imaging technologies ahead of the AF Symposium. The company will present Omny-AF pilot data on Feb. 6 and its stock will trade ex-dividend on Feb. 24. Medtronic announced a $585 million CathWorks acquisition as PFA competition intensifies.
3 February 2026
·····
Intuitive Surgical stock slips into the weekend: ISRG traders eye insider sale, tariffs, and what comes next

Intuitive Surgical stock slips into the weekend: ISRG traders eye insider sale, tariffs, and what comes next

Intuitive Surgical shares fell 0.7% to $504.22 Friday after a filing showed Chief Medical Officer Myriam Curet sold 126 shares under a 10b5-1 plan. The stock traded between $501.44 and $510.75 on volume of 1.7 million. Investors are watching for signs of procedure growth and tariff impacts ahead of quarterly earnings.
1 February 2026
·····
Intuitive Surgical stock in focus after FDA clears da Vinci 5 for heart procedures

Intuitive Surgical stock in focus after FDA clears da Vinci 5 for heart procedures

Intuitive Surgical shares rose nearly 1% to $528.81 after U.S. regulators cleared its da Vinci 5 system for select cardiac procedures. The FDA approval covers thoracoscopic cardiac surgeries using non-force feedback tools. TD Cowen started coverage with a Buy rating and a $660 price target. About 17,000 da Vinci cardiac procedures were performed globally in 2025.
27 January 2026
···
ISRG stock edges up after Intuitive Surgical wins FDA clearance for da Vinci 5 heart procedures

ISRG stock edges up after Intuitive Surgical wins FDA clearance for da Vinci 5 heart procedures

Intuitive Surgical shares rose about 1% after the FDA cleared its da Vinci 5 robot for select cardiac procedures. The company plans a limited U.S. rollout through 2026. The clearance follows last week’s warning of slower global procedure growth, with forecasts now at 13% to 15% for 2026. Investors are weighing the new approval against concerns over hospital budgets and rising competition.
26 January 2026
····
Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares closed at $523.99 Friday, down 0.4% after the company forecast da Vinci procedure growth of 13%–15% by 2026 and warned tariffs could pressure margins. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted earnings of $2.53 per share. The company reported over 20 million da Vinci procedures worldwide. FDA cleared new cardiac uses for its da Vinci 5 robot.
25 January 2026
·····
Intuitive Surgical stock slips into weekend after earnings beat, with tariffs and 2026 outlook in focus

Intuitive Surgical stock slips into weekend after earnings beat, with tariffs and 2026 outlook in focus

Intuitive Surgical shares closed Friday at $523.99, down 0.4%, after the company beat quarterly estimates but projected slower da Vinci procedure growth and flagged higher tariff costs for 2026. The firm reported Q4 revenue of $2.87 billion and installed 532 da Vinci systems. U.S. markets remain closed until Monday. Investors focused on tariffs and hospital demand signals heading into next week.
25 January 2026
·····
Intuitive Surgical stock slips as 2026 growth outlook cools — what to watch before Monday

Intuitive Surgical stock slips as 2026 growth outlook cools — what to watch before Monday

Intuitive Surgical shares fell 0.35% to $523.99 Friday after the company forecast 13%-15% procedure growth for 2026 and warned tariffs could cut margins by 1.2% of revenue. Fourth-quarter revenue rose 19% to $2.87 billion, with da Vinci 5 placements up but Ion placements down. The FDA cleared da Vinci 5 for select cardiac procedures this week.
24 January 2026
·····
Boston Scientific stock (BSX) climbs as heart-rhythm rivalry and deal risk stay in play

Boston Scientific stock (BSX) climbs as heart-rhythm rivalry and deal risk stay in play

Boston Scientific shares rose about 1% to $92.20 Friday, outperforming a weaker healthcare sector as investors focused on pulsed-field ablation for atrial fibrillation. The company’s $14.5 billion deal to buy Penumbra and its upcoming Feb. 4 earnings report are drawing scrutiny. Johnson & Johnson posted $24.6 billion in quarterly sales and gave 2026 guidance, while Medtronic and Abbott shares fell.
23 January 2026
····
Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical shares fell 0.2% to $524.65 after the company forecast slower da Vinci procedure growth of 13–15% for 2026, down from 18% in 2025. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted profit topping estimates. Management cited tariff risks and rising competition as headwinds. The company installed 532 da Vinci systems in Q4, bringing its total to 11,106.
23 January 2026
·····
1 2 3 … 6

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop